{
    "clinical_study": {
        "@rank": "122558", 
        "arm_group": [
            {
                "arm_group_label": "RA-arm", 
                "arm_group_type": "Placebo Comparator", 
                "description": "RA-arm: the patients in this arm will receive intrathecal anaesthesia consisting of bupivacaine 15 mg"
            }, 
            {
                "arm_group_label": "GA-arm, remifentanil", 
                "arm_group_type": "Experimental", 
                "description": "GA-arm: patients in this arm will receive general anaesthesia consisting of Target Controlled Infusion (TCI) of remifentanil and propofol"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether general anaesthesia or regional\n      anaesthesia is best for patients undergoing Total Hip Arthroplasty."
        }, 
        "brief_title": "General or Regional Anesthesia for Hip Surgery", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis", 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "detailed_description": {
            "textblock": "A randomized controlled trial (RCT) with a follow up time of 48 hrs. Patients scheduled for\n      primary Total Hip Arthroplasty. A total of 120 patients randomly assigned to one of the two\n      alternatives (general anaesthesia (GA) or regional anaesthesia (RA)).\n\n      General anaesthesia compared to intrathecal anaesthesia will give shorter length of hospital\n      stay (LOS) for patients undergoing total hip arthroplasty (THA).\n\n      Primary endpoint:\n\n      LOS.\n\n      Secondary endpoints:\n\n      Postoperative pain? Postoperative orthostatic function (dizziness) Time until the patient\n      meets the discharge criteria from PACU How many patients will need at least one urinary\n      bladder catheterisation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: patients with osteoarthritis scheduled for surgery\n\n          -  patients that will require THA\n\n          -  patients over 45 yrs and under 85 yrs.\n\n          -  patients that understand the given information and are willing to participate in this\n             study\n\n          -  patients who have signed the informed consent document.\n\n          -  patients belonging to ASA class I-III.\n\n        Exclusion Criteria:\n\n          -  prior surgery to the same hip\n\n          -  patients with a history of stroke, neurological or psychiatric disease that\n             potentially could affect the perception of pain\n\n          -  obesity (BMI > 35)\n\n          -  active or suspected infection\n\n          -  patients taking opioids or steroids\n\n          -  patients suffering from rheumatoid arthritis or an immunological depression\n\n          -  patients who are allergic to any of the drugs being used in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "84 Years", 
            "minimum_age": "46 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733472", 
            "org_study_id": "Hip-CPH-2013", 
            "secondary_id": "H\u00e4ssleholm2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "GA-arm, remifentanil", 
                "description": "Remifentanil and propofol will be delivered intravenously via TCI pumps according to the \"Marsh\" and \"Minto\" algorithm", 
                "intervention_name": "GA-arm, remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "GA: TCI consisting of remifentanil an dpropofol"
            }, 
            {
                "arm_group_label": "RA-arm", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "anaesthetic techniques", 
            "subarachnoid", 
            "analgesia"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "contact": {
                "email": "andreas.harsten@skane.se", 
                "last_name": "Andreas Harsten, M.D.", 
                "phone": "+46 768 870567"
            }, 
            "facility": {
                "address": {
                    "city": "H\u00e4ssleholm", 
                    "country": "Sweden", 
                    "zip": "28125"
                }, 
                "name": "Dept Orthopedic Surgey, H\u00e4ssleholm Hospital, PO Box 351,"
            }, 
            "investigator": {
                "last_name": "Andreas Harsten, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty", 
        "other_outcome": {
            "description": "Time until the patient meets the discharge criteria from PACU will be monitored every 15 min from teh time the patient arrives to PACU until he/she meets the discharge criteria", 
            "measure": "Time until the patient meets the discharge criteria from PACU", 
            "safety_issue": "No", 
            "time_frame": "12 hrs"
        }, 
        "overall_contact": {
            "email": "andreas.harsten@skane.se", 
            "last_name": "Andreas Harsten, M.D.", 
            "phone": "+46 768 870567"
        }, 
        "overall_official": {
            "affiliation": "Region Skane", 
            "last_name": "Andreas Harsten, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: The National Board of Health and Welfare", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time from the end of surgery until the patients meets the discharge criteria will be evaluated", 
            "measure": "Length of hospital stay", 
            "safety_issue": "No", 
            "time_frame": "4 days after surgery"
        }, 
        "reference": [
            {
                "PMID": "18211990", 
                "citation": "Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2008 Feb;100(2):154-64. Review."
            }, 
            {
                "PMID": "2361330", 
                "citation": "Marsh BJ, Morton NS, White M, Kenny GN. A computer controlled infusion of propofol for induction and maintenance of anaesthesia in children. Can J Anaesth. 1990 May;37(4 Pt 2):S97."
            }, 
            {
                "PMID": "9009936", 
                "citation": "Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997 Jan;86(1):24-33."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733472"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Region Skane", 
            "investigator_full_name": "Andreas Harsten", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Pain will be monitored using a Visual Analogue Scale. Pain will be monitored with the patient in four different positions", 
            "measure": "Post operative pain", 
            "safety_issue": "No", 
            "time_frame": "from end of surgey until 48 hrs later"
        }, 
        "source": "Region Skane", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Region Skane", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}